Matinas BioPharma
MTNB
MTNB
22 hedge funds and large institutions have $194K invested in Matinas BioPharma in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
90% less capital invested
Capital invested by funds: $1.97M → $194K (-$1.78M)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$36.2K | |
| 2 | +$27.6K | |
| 3 | +$13.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.68K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$53 |
Top Sellers
| 1 | -$457K | |
| 2 | -$122K | |
| 3 | -$72.9K | |
| 4 |
JEST
JTC Employer Solutions Trustee
St Helier,
Jersey
|
-$72K |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$24.4K |